Send to a Friend
Death of a Drug: The Aftermath of Merck's Recall
From:
To:
(subscription not required for recipient)
Enter a personalized message:
[Begin Message]
Message Body:
******************************** Death of a Drug: The Aftermath of Merck's Recall http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&id=1058 Wharton management professor Michael Useem, director of the school's Center for Leadership and Change Management, notes that one of the key mantras in corporate crisis management is: "Hide nothing, tell all." Less than a week after Merck & Co.'s voluntary withdrawal of its blockbuster arthritis pain medication Vioxx, following an extended clinical trial that linked the drug to heart attacks and strokes, the jury is still out on whether the pharmaceutical giant followed this cardinal rule. Wharton professors debate Merck's response to the crisis and the impact of the recall.
Finance and Investment
Leadership and Change
Executive Education
Marketing
Insurance and Pensions
Health Economics
Strategic Management
Real Estate
Law and Public Policy
Human Resources
Business Ethics
Innovation and Entrepreneurship
Operations Management
Managing Technology
Knowledge@Wharton
Visit The Wharton School of the University of Pennsylvania
Return to Home Page
Special Sections
Podcasts
Sponsors
News Room
Knowledge
Today
Feedback
Home
